| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 625-626 |
| Número de páginas | 2 |
| Publicación | JAMA Otolaryngology - Head and Neck Surgery |
| Volumen | 151 |
| N.º | 6 |
| DOI |
|
| Estado | Published - jun 12 2025 |
Financiación
Conflict of Interest Disclosures: Dr Saba reports personal fees from AstraZeneca, Eisai Medical, Exelixis/Merck, Merck, EMD Serono, Pfizer, Kura, Vaccinex, CUE, BionTech, GSK, TOSK, Seagen, Flamingo, Infinity, Inovio, Aveo, Medscape, Onclive, UpToDate, BMS, Cornerstone, Celldex, Surface Oncology, Urogen, Astex, Imugene, Faron Pharmaceutical, Coherus, Adagene, Fulgent Springer, Nanobiotix, and Taiho and funding from Exelixis and BMS outside the submitted work. No other disclosures were reported.
| Financiadores |
|---|
| GlaxoSmithKline |
| TOSK |
| Exelixis Inc. |
| Bamfield Marine Sciences Centre |
ASJC Scopus subject areas
- Surgery
- Otorhinolaryngology